Johnson & Johnson
JNJ
#24
Rank
A$592.71 B
Marketcap
$246.22
Share price
-0.40%
Change (1 day)
-2.98%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

Revenue for Johnson & Johnson (JNJ)

Revenue in 2024 (TTM): A$130.97 B

According to Johnson & Johnson's latest financial reports the company's current revenue (TTM) is A$129.85 B. In 2023 the company made a revenue of A$124.99 B a decrease over the revenue in the year 2022 that were of A$133.94 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Johnson & Johnson from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) A$130.97 B4.78%
2023 A$124.99 B-6.68%
2022 A$133.94 B3.86%
2021 A$128.96 B20.34%
2020 A$107.17 B-8.19%
2019 A$116.73 B0.84%
2018 A$115.76 B18.22%
2017 A$97.92 B-1.81%
2016 A$99.73 B3.67%
2015 A$96.20 B6.13%
2014 A$90.64 B13.38%
2013 A$79.95 B23.31%
2012 A$64.83 B2.23%
2011 A$63.42 B4.26%
2010 A$60.83 B-12.1%
2009 A$69.20 B-25.02%
2008 A$92.29 B32.01%
2007 A$69.91 B3.36%
2006 A$67.64 B-2.02%
2005 A$69.03 B12.83%
2004 A$61.18 B8.64%
2003 A$56.31 B-12.58%
2002 A$64.42 B1.19%
2001 A$63.67 B20.53%
2000 A$52.82 B24.76%
1999 A$42.34 B9.59%
1998 A$38.63 B11.24%
1997 A$34.73 B27.62%
1996 A$27.21 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
A$83.45 B-35.73%๐Ÿ‡บ๐Ÿ‡ธ USA
A$93.71 B-27.83%๐Ÿ‡บ๐Ÿ‡ธ USA
A$73.28 B-43.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$76.69 B-40.93%๐Ÿ‡ซ๐Ÿ‡ท France
A$32.08 B-75.29%๐Ÿ‡บ๐Ÿ‡ธ USA
A$48.86 B-62.37%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
A$58.37 B-55.04%๐Ÿ‡บ๐Ÿ‡ธ USA
A$61.08 B-52.96%๐Ÿ‡บ๐Ÿ‡ธ USA
A$59.19 B-54.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$41.70 B-67.89%๐Ÿ‡บ๐Ÿ‡ธ USA